Patents by Inventor Uwe Bamberger

Uwe Bamberger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030143229
    Abstract: Recombinant antibody proteins are provided that specifically bind fibroblast activation protein alpha (FAP&agr;) and comprise framework modifications resulting in the improved producibility in host cells. The invention also relates to the use of said antibodies for diagnostic and therapeutic purposes and methods of producing said antibodies.
    Type: Application
    Filed: June 3, 2002
    Publication date: July 31, 2003
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: John Edward Park, Pilar Garin-Chesa, Uwe Bamberger, Wolfgang J. Rettig, Olivier Leger, Jose William Saldanha
  • Patent number: 6455677
    Abstract: Recombinant antibody proteins are provided that specifically bind fibroblast activation protein alpha (FAP&agr;) and comprise framework modifications resulting in the improved producibility in host cells. The invention also relates to the use of said antibodies for diagnostic and therapeutic purposes and methods of producing said antibodies.
    Type: Grant
    Filed: April 29, 1999
    Date of Patent: September 24, 2002
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: John Edward Park, Pilar Garin-Chesa, Uwe Bamberger, Wolfgang J. Rettig, Olivier L├Ęger, Jose William Saldanha
  • Publication number: 20020052480
    Abstract: Recombinant antibody proteins are provided that specifically bind fibroblast activation protein alpha (FAP&agr;) and comprise framework modifications resulting in the improved producibility in host cells. The invention also relates to the use of said antibodies for diagnostic and therapeutic purposes and methods of producing said antibodies.
    Type: Application
    Filed: April 29, 1999
    Publication date: May 2, 2002
    Inventors: JOHN EDWARD PARK, PILAR GARIN-CHESA, UWE BAMBERGER, WOLFGANG J. RETTIG, OLIVIER LEGER, JOSE WILLIAM SALDANHA
  • Patent number: 5618814
    Abstract: The invention relates to trisubstituted pyrimido [5,4-d]-pyrimidines of general formula ##STR1## (wherein R.sub.a, R.sub.b and R.sub.c are defined as in claim 1) and the salts thereof, more particularly for pharmaceutical use the physiologically acceptable salts thereof, which have, inter alia, valuable pharmacological properties, particularly in chemotherapy a sensitizing effect on resistant tumors, the use thereof and processes for preparing them.
    Type: Grant
    Filed: August 2, 1994
    Date of Patent: April 8, 1997
    Assignee: Dr. Karl Thomae GmbH
    Inventors: Armin Heckel, Uwe Bamberger, Annerose Mauz